CLINICAL_TRIALS trial_result · 2020-07-01

Clinical Trial Update: 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes [Phase 1]

A Phase 1 multi-dose, dose-escalation study in patients with Type 2 Diabetes Mellitus has been completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2020-07-01